Built to help voters verify how officials vote using official public records — non-partisan, no spin, no jargon.
H.R. 1750 · 119th Congress

HEARD Act of 2025

In committee

See what this could mean for your district

Save your district in Account to view district-specific context for this bill.

Bill details

Introduced: 2/27/2025
Current status: In committee
Bill ID: 119hr1750
Latest official action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Bill overview

A neutral overview based on official congressional sources.

Introduced in House

Health Equity and Rare Disease Act of 2025 or the HEARD Act of 2025 This bill establishes Department of Health and Human Services (HHS) grants and other initiatives to address rare diseases or conditions (e.g., those affecting less than 200,000 people in the United States) in racial and ethnic minority populations. For example, to advance such purposes, the bill establishes within HHS • grants to public and private nonprofit entities for data collection and public outreach, • grants to health professions schools to improve health care and minority representation in research regarding rare diseases and conditions, • grants to tribal epidemiology centers and tribal and urban Indian health centers for research regarding rare diseases and conditions in tribal communities, • scholarships and educational loan repayment for medical school students who agree to work as health care professionals serving populations with rare diseases or conditions, • initiatives to coordinate research and other activities across the National Institutes of Health, and • public health awareness and education campaigns. Also, the bill requires HHS to submit various reports to Congress on topics including (1) the federal government’s research and public health activities regarding rare diseases or conditions in minority populations, (2) regulatory barriers to treating rare diseases in Medicare beneficiaries of color, and (3) strategies for research and development of treatments for rare diseases or conditions that disproportionately impact minority populations.

Source: BILLSUM · Summary date: 2/27/2025

Related votes

Roll calls that reference this bill in official data.

0 roll calls
No related roll calls found yet for this bill.

Primary sources

Official links to verify details. No interpretation.

About this data

Non-partisan by design
OurCongress presents public records without political endorsement, interpretation, or advocacy.
Official sources
Data is sourced from official government records, including Congress.gov, GovInfo, the Clerk of the House, and the U.S. Senate.
AI-generated text
Some explanatory sections may be generated from official summaries and metadata to improve readability. They are not official government language and should be verified against primary sources.
Last updated: 3/30/2026Source: BILLSUMBill: 119hr1750Learn more →